- 英文名称
- Rolofylline
- 分子式
- C20H28N4O2
- 分子量
- 356.46
- 中文别名
- 1,3-二丙基-8-(3-正金刚烷基)黄嘌呤; Kw 3902; MK-7418; 1,3-Dnax; KW-3902; 8-(3-Noradamantyl)-1,3-dipropylxanthine; 8-(Noradamantan-3-yl)-1,3-dipropylxanthine; Rolofyllina; 1,3-DIPROPYL-8-(TRICYCLO(3.3.1.0(SUP 3,7))NON-3-YL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE; 3,7-DIHYDRO-1,3-DIPROPYL-8-(3-TRICYCLO(3.3.1.0(SUP 3,7))NONYL)-1H-PURINE-2,6-DIONE; rolofyllinum; 1,3-Dipropyl-8-(3-noradamantyl)xanthine; MK7418; 1,3-dipropyl-8-((1R,5S)-tricyclo(3.3.1.0^(3,7))nonan-3-yl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione; KW3902; 8-(Hexahydro-2,5-methanopentalen-3a(1H)-yl)-3,7-dihydro-1,3-dipropyl-1H-purine-2,6-dione; 1,3-Dipropyl-8-(tricyclo(3.3.1.0(3,7))non-3-yl)-3,7-dihydro-1H-purine-2,6-dione; 1,3-dipropyl-8-[(1R,5S)-3-tricyclo[3.3.1.03,7]nonanyl]-7H-purine-2,6-dione; 3,7-Dihydro-1,3-dipropyl-8-(3-tricyclo(3.3.1.0(3,7))nonyl)-1H-purine-2,6-dione; HMR-4902
- 用途
- 化学合成;作为选择性腺苷A1受体拮抗剂,用于急性充血性心力衰竭和肾功能损害研究;可减轻突触前功能障碍,恢复体外神经元活动及树突棘水平,对抗Tau诱导的神经退行性疾病相关代谢减退及神经功能障碍。